Why would atropine be administered sublingually?

Why Atropine Would Be Administered Sublingually

Atropine is administered sublingually primarily to manage excessive salivation (sialorrhea), particularly in patients taking clozapine or those with neurological conditions causing drooling, because this route provides effective local anticholinergic action while minimizing systemic side effects.

Primary Indication: Sialorrhea Management

The sublingual route for atropine is specifically used to reduce excessive salivation in several clinical contexts:

Clozapine-Induced Sialorrhea

Sublingual atropine (typically as 1% ophthalmic drops) is an effective treatment option for clozapine-induced sialorrhea, though guidelines specifically warn about its lethality in overdose 1. The 2026 Lancet Psychiatry consensus guidelines note that while ipratropium sublingual spray is preferred due to lower adverse drug reaction rates, atropine sublingual drops can be used but require extreme caution given overdose risk 1.

Neurological Conditions

Sublingual atropine effectively treats sialorrhea from:

• Stroke: One drop of 1% atropine eye drops sublingually three times daily significantly reduced sialorrhea scores (from 5.12 to 3.94, p<0.01) compared to rehabilitation alone 2
• Cerebral palsy and brain injury: Studies show beneficial effects in children and adults with neurological disabilities 3, 4
• Parkinson's disease and ALS: Effective for managing excessive drooling in neurodegenerative conditions 3

Practical Administration Details

Dosing

• Standard dose: 1-2 drops of 1% atropine ophthalmic solution, 2-3 times daily 5
• Pediatric use: One drop daily, potentially increased to twice daily based on response 4

Route Superiority

Sublingual administration is superior to oral and subcutaneous routes for reducing salivary flow 3. The sublingual route provides:

• Direct local effect on salivary glands
• Reduced systemic absorption compared to oral administration
• Faster onset than transdermal routes
• More practical than subcutaneous injection

Alternative Emergency Use

Nerve Agent Countermeasure

Sublingual atropine has been studied as an alternative route for organophosphate/nerve agent poisoning when IV access is unavailable 6. A 1.0 mg sublingual dose achieved 60% of the bioavailability of IV administration (AUC∞ ratio 0.60,90% CI: 0.55-0.66), making it a potential mass casualty countermeasure option 6.

Laryngospasm Management

In anesthesia, sublingual atropine (4.0 mg/kg) has been proposed as an alternative to IV/IM administration for managing laryngospasm when other routes are unavailable 7.

Critical Safety Warnings

Overdose Risk

The most important caveat is that atropine sublingual drops can be lethal in overdose 1. This risk is particularly concerning because:

• Patients may self-administer at home
• The ophthalmic formulation is concentrated (1%)
• Anticholinergic toxicity can progress rapidly to delirium, seizures, and death

Side Effects

Common adverse effects include:

• Dry mouth (xerostomia)
• Unpleasant taste
• Short duration of action requiring multiple daily doses 5
• Potential systemic absorption causing typical anticholinergic symptoms 8

Administration Challenges

Parents and caregivers report difficulty with sublingual administration technique, particularly in children with disabilities 4.

Clinical Decision Algorithm

For clozapine-induced sialorrhea:

1. First-line: Ipratropium sublingual spray (lower ADR profile) 1
2. Second-line: Atropine sublingual drops if ipratropium ineffective
3. Ensure patient/caregiver education about overdose risk
4. Start with 1 drop 2-3 times daily, titrate based on response

For neurological sialorrhea (stroke, CP, Parkinson's):

1. Trial sublingual atropine 1% ophthalmic drops
2. Dose: 1-2 drops sublingually 2-3 times daily
3. Monitor for efficacy using objective scales (Drooling Severity Scale, Sialorrhea Scoring Scale)
4. Assess for anticholinergic side effects

The sublingual route should NOT be used for:

• Cardiac bradycardia (use IV route) 9, 10
• Acute organophosphate poisoning requiring immediate high-dose therapy (use IV route) 11, 12